ArticleTranslational lung cancer research2024

Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target.

Kazutaka Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.